← Back to all trials
Not Yet Recruiting
NCT07601321
BCW-Based Resistance Training for Community-Dwelling Sarcopenia Patients
Conditions: Sarcopenia
Sex: All
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 90
Sponsor: Hangzhou Normal University
Location: Tianshui Wulin Sub-district Community Health Service Center Hangzhou Zhejiang
Summary
The purpose of this randomized controlled trial is to evaluate the effects of a Behavior Change Wheel (BCW)-based resistance exercise program on muscle health, physical performance, and exercise adherence in community-dwelling older adults with sarcopenia. Participants will be randomly assigned to either an experimental group or a waitlist control group. The experimental group will receive a 12-week BCW-based resistance exercise intervention (twice a week) immediately. The waitlist control group will maintain their usual routine for the first 3 months for comparison, and will then cross over to receive the identical 12-week intervention. The study aims to provide an effective and ethical exercise management strategy for sarcopenic patients.
Eligibility Criteria
Inclusion Criteria:
Meet the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) 2025:
Low muscle mass (SMI measured by BIA): For age ≥ 65, Male \< 7.0 kg/m², Female \< 5.7 kg/m²; For age 50-64, Male \< 7.6 kg/m², Female \< 5.7 kg/m².
Low muscle strength (Handgrip strength): For age ≥ 65, Male \< 28 kg, Female \< 18 kg; For age 50-64, Male \< 34 kg, Female \< 20 kg.
Ability to walk independently without assistive devices.
Clear consciousness and stable medical condition.
Willingness to participate, commit to the exercise protocol, and provide signed informed consent.
Proficiency in using a smartphone.
Exclusion Criteria:
* Presence of metal implants, such as cardiac pacemakers, stents, steel plates, or artificial joints (due to BIA measurement constraints).
Cognitive impairment, epilepsy, other neurological disorders, or severe mental illness that prevents cooperation with the study.
Inability to complete the exercise intervention due to severe cardiovascular or musculoskeletal diseases.
Severe organ dysfunction (e.g., heart failure), organ failure, or active infection.
Inability to maintain adherence or significant missing data (participants who withdraw or are lost to follow-up).
Source: ClinicalTrials.gov (NCT07601321). StuddyBuddy aggregates publicly available trial information.
